The ability of BAPN to reduce leptin levels in vivo and prevent the leptin-mediated induction of profibrotic mediators and ROS in cardiac cells suggests that the interaction between leptin and LOX regulates downstream signaling pathways underlying the development of myocardial fibrosis in obesity. This evidence concerns the gene LEP and Myocardial fibrosis.